The Bone Growth Stimulator Market is set to experience significant growth, according to Emergen Research, with a projected worth of USD 3.80 Billion by 2032. VANCOUVER, Canada - April 20, 2023 — The ...

(MENAFN- EIN Presswire) EINPresswire/ -- The global bone growth stimulator market is expected to reach US$ 2.5 billion in 2026 and grow to US$ 3.7 billion by 2033, at a CAGR of 5.6% during the ...

The global bone growth stimulator market is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. Escalating demand for noninvasive and minimally invasive ...

Bone Growth Stimulator Market Report by TBRC covers the bone growth stimulator market drivers and restraints, size, major players, and the impact of COVID-19 LONDON ...

DUBLIN--(BUSINESS WIRE)--The "Bone Growth Products Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Bone Growth Products Market was valued at USD ...

Please provide your email address to receive an email when new articles are posted on . Theragen Inc. has announced the issuance of a U.S. patent for the ActaStim-S, a spine fusion bone-growth ...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) ...

Please provide your email address to receive an email when new articles are posted on . Xstim Inc. received FDA premarket application approval of its Xstim spine fusion stimulator. The device is ...

JACKSONVILLE, Fla., Aug. 18, 2022 /PRNewswire/ -- Medical device company Theragen is pleased to announce the issuance of a U.S. Patent acknowledging its innovative approach to the development of the ...

obstruction of a June 2008 federal audit; charges were recorded in Q1 2011 * Says this final settlement also includes the resolution of a related qui tam category S&P 500 ekes out all-time closing ...